Last updated: October 30, 2026.
Quick answer
A cancer screening panel is a set of tests chosen to catch early cancer, not a general health check. A standard annual physical covers blood pressure, weight and basic blood work, but skips cancer-specific tests like a low-dose CT or colonoscopy unless your doctor orders them. That gap is real: fewer than one in five eligible Americans get lung cancer screening.
What's the difference between an annual physical and a cancer screening panel?
A routine US physical checks your general health. It is built around blood pressure, weight, cholesterol, blood sugar and a short symptom review, aimed at catching common chronic conditions. None of those tests are designed to find early-stage cancer, and a normal result on all of them does not rule cancer out.
A cancer screening panel is narrower by design. It bundles the specific tests tied to your age, sex and risk factors: imaging like a low-dose CT or mammogram, a colonoscopy or stool test, and sometimes a blood panel. Oncologists describe this gap directly. "Routine checkups mainly assess your baseline health. Because of limited sensitivity, they can miss an early-stage tumor," said Dr. Zhang Jianwei, acting deputy director of oncology at Sun Yat-sen University's Sixth Affiliated Hospital, in a hospital patient-education article. A clean annual physical and an undetected early cancer can both be true at the same time.
For the full age-by-age US screening schedule (which test, which age, how often), see Goji Health's health screenings after 55 checklist. This article instead focuses on the physical-vs-panel distinction, family-history-driven early screening, and what a panel costs and catches in practice.
Which cancers are most common in the US, and which have a screening test
The American Cancer Society projects about 2.11 million new cancer cases in the US for 2026, with roughly 626,140 deaths. Lung cancer alone accounts for an estimated 229,410 of those new cases. Four cancer types have a screening test with established US guidelines behind it:
| Cancer | Recommended test | Who | Starting age |
|---|---|---|---|
| Lung | Low-dose CT (LDCT) | Adults who smoke or quit within 15 years, 20+ pack-year history | 50 |
| Colorectal | Colonoscopy or stool test | Average-risk adults | 45 |
| Breast | Mammogram | Women | 40 |
| Prostate | PSA blood test | Men, shared decision with a doctor | 55-69 |
Source: US Preventive Services Task Force recommendation statements, linked above. Thyroid ultrasound and tumor marker blood tests are not on this list. Neither has a USPSTF recommendation for screening people without symptoms, a point covered in the next section.
Why screening rates stay low even when a test is recommended
Having a recommended test is not the same as getting it. Colorectal cancer screening, one of the better-adopted tests, still reached only 61.4% of eligible US adults aged 45 to 75 in 2022, according to the CDC's BRFSS survey. That is below the federal Healthy People 2030 target of 72.8%.
Lung cancer screening lags far more. A 2024 National Health Interview Survey analysis, published in JAMA in November 2025, drew on a nationally representative sample size covering 12.76 million Americans eligible under USPSTF criteria. Just 18.7% were up to date. A separate BRFSS-based analysis in JAMA Internal Medicine put the figure closer to 1 in 4, still describing it as rising from a low base. Either number means most people who qualify for a test proven to cut lung cancer deaths are not getting it.
When family history or genetics should move screening earlier
Family history changes the math on when to start. Clinical guidelines for hereditary cancer syndromes, most often summarized from NCCN guidance, recommend moving screening up by years, not adjusting it at the margins:
- Lynch syndrome (an inherited condition that raises colorectal and other cancer risk): colonoscopy starting at age 20-25, or 10 years before the youngest relative's diagnosis, whichever comes first.
- BRCA1/BRCA2 mutations (linked to breast and ovarian cancer): breast awareness starting at 18, with risk-reducing surgery options discussed from the mid-30s to mid-40s depending on the specific gene and family history.
- A first- or second-degree relative diagnosed with breast cancer before age 50: this alone is a trigger for genetic testing under current NCCN-aligned guidance, not something to wait on until your own screening age arrives.
None of this applies if you have no known family history or genetic result. For average-risk adults, the ages in the table above still apply. If a parent, sibling or child had colorectal, breast or ovarian cancer at an unusually young age, that is the detail to raise with your doctor before your next visit, not after.
Are tumor marker blood tests part of a cancer screening panel?
Some screening packages add blood tests for tumor markers such as CEA, CA19-9 and AFP, marketed as an early-warning check. The evidence does not support using them this way in someone with no symptoms. A 2025 systematic review of 38 studies found no mortality benefit from tumor marker screening in asymptomatic people, and a real risk of harm from chasing false positives into unnecessary follow-up procedures. Goji Health's screenings checklist covers this in more depth, including the USPSTF's parallel finding on CA-125 and ovarian cancer. These tests have a real use once a cancer is already diagnosed, for tracking treatment response, which is a different purpose than screening.
Fact check: the uptake, incidence and cost figures above are drawn from the CDC, the American Cancer Society, USPSTF recommendation statements and the cash-price sources listed below, not from the original hospital source material alone.
What a cancer screening panel costs in the US
Self-pay prices vary by facility and region, and most of these tests cost far less when covered by insurance.
| Test | Typical self-pay price | Source |
|---|---|---|
| Low-dose CT (lung) | $99-$452, several hospitals offer a flat $99-$150 rate | MDsave national average; Orlando Health published self-pay rate |
| Mammogram (2D) | $125-$400, regional averages cluster near $300-$390 | MDsave regional listings; KQED PriceCheck |
| Colonoscopy | $1,000-$4,000+ without insurance | Multiple healthcare cost-comparison sources; figures are indicative, not a single published list price |
Under the Affordable Care Act, a screening colonoscopy for an average-risk adult 45 to 75 must be covered at 100% by in-network insurance, with no cost-sharing, when billed as a screening rather than diagnostic procedure. The same protection generally applies to mammograms and lung cancer screening for people who meet the eligibility criteria. The self-pay prices above matter mainly if you are uninsured, your plan has a high deductible, or you want a test outside the age or risk window your insurer will cover.
Can international patients get a dedicated cancer screening panel in China?
International departments at hospitals in cities such as Beijing and Shanghai package many of these tests into a single visit, often alongside imaging and specialist consultations that would otherwise take several separate US appointments to arrange. Goji Health's cost comparison across the US, UK and China covers the full range for general health screening packages. The same caution applies to a cancer-focused version of that package. Check which specific tests are included. A lower listed price does not by itself tell you whether a package covers the same scope as what you would get at home.
Common mistakes with cancer screening panels
- Assuming a clean annual physical already covers cancer screening, when none of its standard tests are designed to detect early-stage cancer.
- Treating a tumor marker blood test as an early-warning system, when current evidence shows no mortality benefit for screening people without symptoms.
- Waiting until your own age threshold to ask about family history, instead of raising it as soon as you know a close relative was diagnosed young.
- Skipping a recommended test because it "sounds unnecessary," when actual uptake for even well-established tests like colorectal screening sits well below the national target.
FAQ
What is a cancer screening panel?
A cancer screening panel is a set of tests chosen for your specific age, sex and risk factors to catch cancer early, such as a low-dose CT for lung cancer or a colonoscopy for colorectal cancer. It is different from a general annual physical, which checks baseline health markers like blood pressure and cholesterol.
Does an annual physical screen for cancer?
Not on its own. A standard US physical does not automatically include cancer-specific tests like a low-dose CT, mammogram or colonoscopy. Those get added only when your age, sex or risk factors call for them, and only if you or your doctor brings them up.
Why is lung cancer screening uptake so low in the US?
Only 18.7% of Americans eligible for lung cancer screening were up to date in 2024, according to a National Health Interview Survey analysis published in JAMA. The exact reasons vary, but low awareness of eligibility and the newer rollout of the test compared to colorectal or breast screening are common factors cited in the research.
Should I get tumor marker blood tests as part of a screening panel?
Current evidence does not support tumor marker tests like CEA, CA19-9 or AFP as a general cancer screen for people without symptoms. A 2025 systematic review found no mortality benefit and a real risk of harm from false positives. They are more useful for monitoring a cancer that has already been diagnosed.
At what age should I start cancer screening if a parent had cancer young?
It depends on the cancer and the relative's age at diagnosis. The common pattern is starting 5-10 years before that relative's diagnosis age, or at a fixed earlier age set by guidelines for conditions like Lynch syndrome or BRCA1/BRCA2 mutations. Ask your doctor about genetic counseling rather than guessing at a starting age.
Sources
- American Cancer Society, Cancer Facts & Figures 2026. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2026-cancer-facts-figures.html
- Centers for Disease Control and Prevention, BRFSS 2022 colorectal cancer screening brief, Preventing Chronic Disease. https://www.cdc.gov/pcd/issues/2025/pdf/25_0175.pdf
- Bandi et al., 2024 National Health Interview Survey lung cancer screening analysis, JAMA, November 19, 2025. https://jamanetwork.com/journals/jama/fullarticle/2841694
- BRFSS-based lung cancer screening uptake analysis, JAMA Internal Medicine, 2026. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2848035
- US Preventive Services Task Force, Lung Cancer: Screening (2021). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
- US Preventive Services Task Force, Colorectal Cancer: Screening (2021). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
- US Preventive Services Task Force, Breast Cancer: Screening (2024 final recommendation). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
- US Preventive Services Task Force, Prostate Cancer: Screening (2018). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening1
- "Inappropriate Use of Tumor Markers in Asymptomatic Patients: A Systematic Review and Proposed Follow-Up Algorithm" (2025). https://journal.waocp.org/article_92301.html
- NCCN-based clinical guidance summaries on Lynch syndrome and BRCA1/BRCA2 screening ages, via UCSF Lynch Syndrome Center and Natera clinical resources. https://lynchsyndromecenter.ucsf.edu/node/31 ; https://www.natera.com/resource-library/empower/nccn-guideline-updates-for-hereditary-cancer-screening/
- MDsave, national average and regional cash-price listings for low-dose CT lung screening and 2D mammogram screening (cash-pay marketplace, cited as indicative pricing, not an official hospital source). https://www.mdsave.com/procedures/low-dose-ct-lung-screening/d785f5cf/california/sonora-ca ; https://www.mdsave.com/mammogram
- Healthcare.gov, Affordable Care Act preventive service coverage rules for screening colonoscopy, mammography and lung cancer screening. https://www.healthcare.gov/coverage/preventive-care-benefits/
- Source material for this article: 中山大学附属第六医院 (Sun Yat-sen University Sixth Affiliated Hospital / "中山六院"), "这些检查项目能有效筛查癌症！你做对了么？" (expert: Dr. Zhang Jianwei), April 25, 2026. https://mp.weixin.qq.com/s/Mcarr65WCod3boGSy8lVCA
Last verified: October 30, 2026.
How Goji Health can help
Goji Health is a US-China operated medical coordination company. We do not diagnose or treat. We handle the process of getting an international patient to the right hospital in China and home again.
It starts with a case review. You send your medical records, our team goes through them with experienced Chinese general practitioners, and we reply within 24-48 hours of receiving the complete file. From there an English-speaking care manager takes you through each step, including what a cancer screening package covers once you decide what you want checked. Health screening packages are sold at one all-in price confirmed when you book, not an itemized list.
Send your records for a case review
This article is for general information and is not medical advice. Guidelines and prices vary by country, insurer and your personal risk factors, so confirm your own screening plan with your doctor.